 posit weather
report solid result revenu line estim ep
ahead model consensu minim impact
anticip signific impact companion livestock
lower outlook reflect well recessionari
environ lower estim maintain hold rate
base risk/reward valuat level said believ
well posit weather storm base scale divers leadership
anim health space strong financi posit
report ep estim consensu
total revenu line estim
consensu us revenu higher expect growth
acceler driven solid growth livestock
companion anim ou growth lower cc vs estim
total revenu line estim gross margin came
higher vs model tax rate lower vs lead
ep upsid
takeaway quarter
view key takeaway ztss revis outlook assum
greatest impact impact livestock
sale companion economi begin open
compani note vet visit us
europ earli april trend recent begun improv
manag expect companion anim market rel resili
recessionari environ similar recess lower
end revenu target assum deep recess
second wave later year quarter includ
stock simparica trio expect growth come quarter
somewhat less plan due us dermatolog
busi particularli strong growth acceler
compani plan care manag expens
pandem remain commit invest medium long-term
reduc revenu revenu
base lower sale livestock companion
tr target
anim due headwind near term recessionari pressur medium term
also lower sg assumpt base compani revis spend plan
new ep ep pt remain
assum stock trade new ebitda repres discount
current multipl ebitda
page
page
expens zoeti inc
page
expens attribut non-control zoeti inc
page
manufacturing/human changeu manufacturing/human oper revenueu manufacturing/human profitexist apoquel gross marginexist apoquel gross zoeti inc
page
manufacturing/human changeu manufacturing/human oper revenueu manufacturing/human profitexist apoquel gross marginexist apoquel gross zoeti inc
zoeti largest anim health compani world sale compani strong
perform sinc spun nr consist above-market revenu
growth signific margin expans well-diversifi revenu base geograph
across companion food anim segment compani expand veterinari
diagnost market acquisit abaxi
despit hold rate stock view best-in-class anim health compani
attract combin sustain organ growth diversifi portfolio low-risk strategi
cash-pay model leverag infrastructur expect base busi drive solid revenu
earn growth next year may supplement select busi
develop new launch said believ attribut larg understood
marketplac would prefer attract entri point thu rate share hold
valuat risk
pt assum stock trade ebitda repres discount
current multipl ebitda downsid risk includ lower growth livestock
companion segment lower growth abaxi lower sale key product apoquel cytopoint
simparica consolid custom and/or competitor global econom downturn advers
fx trend upsid risk includ higher growth livestock companion abaxi higher sale
apoquel cytopoint simparica greater contribut new product
gregg gilbert herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
